Oncology Exclusive Pfizer Speaker Interview Released SMi are delighted to welcome Alison Betts, Associate Research Fellow, Pfizer, onto the speaker panel for day 1 at ADC 2018! www.adcsummit.com/phpr
News Enhertu OK ends 10-year EU gap in frontline breast cancer Enhertu plus Perjeta has become the first new frontline therapy approved for advanced HER2-positive breast cancer in the EU for over a decade.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.